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Abstract
Background: The fecal egg count reduction test (FECRT) is recommended to monitor drug efficacy against soil-transmitted
helminths (STHs) in public health. However, the impact of factors inherent to study design (sample size and detection limit
of the fecal egg count (FEC) method) and host-parasite interactions (mean baseline FEC and aggregation of FEC across host
population) on the reliability of FECRT is poorly understood.
Methodology/Principal Findings: A simulation study was performed in which FECRT was assessed under varying conditions
of the aforementioned factors. Classification trees were built to explore critical values for these factors required to obtain
conclusive FECRT results. The outcome of this analysis was subsequently validated on five efficacy trials across Africa, Asia,
and Latin America. Unsatisfactory (,85.0%) sensitivity and specificity results to detect reduced efficacy were found if sample
sizes were small (,10) or if sample sizes were moderate (10–49) combined with highly aggregated FEC (k,0.25). FECRT
remained inconclusive under any evaluated condition for drug efficacies ranging from 87.5% to 92.5% for a reduced-
efficacy-threshold of 90% and from 92.5% to 97.5% for a threshold of 95%. The most discriminatory study design required
200 subjects independent of STH status (including subjects who are not excreting eggs). For this sample size, the detection
limit of the FEC method and the level of aggregation of the FEC did not affect the interpretation of the FECRT. Only for a
threshold of 90%, mean baseline FEC ,150 eggs per gram of stool led to a reduced discriminatory power.
Conclusions/Significance: This study confirms that the interpretation of FECRT is affected by a complex interplay of factors
inherent to both study design and host-parasite interactions. The results also highlight that revision of the current World
Health Organization guidelines to monitor drug efficacy is indicated. We, therefore, propose novel guidelines to support
future monitoring programs.
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Introduction
Infections with the soil-transmitted helminths (STHs), namely
Ascaris lumbricoides, Trichuris trichiura and hookworm (Necator
americanus and Ancylostoma duodenale) are among the most common
infectious diseases in children of tropical countries causing
malnutrition, growth stunting, intellectual retardation, and
cognitive deficits [1]. Currently, the large-scale administration
of benzimidazole drugs (i.e., albendazole and mebendazole) is the
most widely used method to control morbidity due to STH
infections, and a scale-up of these large-scale treatment programs
is underway in Africa, Asia, and Latin America (donation of 400
million tablets of albendazole by GlaxoSmithKline and 200
million tablets of mebendazole by Johnson & Johnson). Rather
than aiming to achieve eradication, these control programs are
focused on reducing infection intensity and transmission poten-
tial, and hence reduce morbidity [2]. However, due to the
scarcity of alternative anthelmintics, it is imperative that
monitoring systems are designed to detect any change in drug
efficacy due to emerging resistance of the parasites against
benzimidazoles [3–7].
At present, the fecal egg count reduction test (FECRT) is
recommended to monitor anthelmintic efficacy against STH in
animal [8] and public health [9]. Guidelines on how to conduct a
FECRT in public health were published by the World Health
Organization (WHO) in the late 1990s [10], providing recom-
mendations on sample size (,200 infected subjects), stool sampling
(two stool samples of two different days both before and after
administration of drugs), the detection limit of the method to
quantify the number of eggs (Kato-Katz thick smear with a
detection limit of 24 eggs per gram of stool (EPG)) and thresholds
defining reduced efficacy (FECRT ,70% for A. lumbricoides and
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current guidelines have some important weaknesses. At first, the
level of understanding of the effects of the factors inherent both to
study design (sample size, stool sampling and the fecal egg count
(FEC) method) and host-parasite interactions (level of egg
excretion and level aggregation of STH infections across host
populations) to support these guidelines is poor. In veterinary
sciences, there is empirical evidence that low FEC may thwart
interpretation of FECRT results, particularly when sample size is
small and/or detection limit of the FEC method is low [11,12]. As
a consequence of this, it is most likely that performing a FECRT
across the three STHs, would require a different study design, and
this solely due to the differences in fecundity (A. lumbricoides
&hookworm.T. trichiura [1]). Another important issue of the
current guidelines is the additional technical and financial
resources that are required to monitor anthelmintic efficacy.
Based on the cost assessment of the Kato-Katz thick smear for
STH diagnosis by Speich and colleagues in epidemiological
surveys in an African setting [13], it can be deduced that the re-
examination already would require US$ 3.46 per subject.
Therefore, any effort to reduce the cost and the complexity of a
surveillance system is desirable. Finally, recent efficacy trials
performed in seven countries across Africa, Asia, and Latin
America questioned the validity of the thresholds for reduced
efficacy [9], as a single dose of albendazole revealed to be highly
efficacious against both A. lumbricoides (FECRT .99%) and
hookworm (FECRT .90%). As a consequence of this, it was
proposed to adopt the current thresholds of reduced efficacy to
,95% and ,90% for A. lumbricoides and hookworm, respectively.
The aim of the present study was to assess the impact of sample
size, detection limit of the FEC method, level of egg excretion, and
aggregation of FEC on the interpretation of the FECRT. To this
end, data were generated using a statistical simulation and
analyzed using tree based-models. The outcome of these trees
was subsequently validated on five efficacy trials previously
conducted in Africa, Asia, and Latin America. From the results,
we propose cost-effective study designs to successfully monitor
anthelmintic drug efficacy in future anthelmintic treatment
programs.
Methods
The study consisted of three consecutive methodological proce-
dures. First, data were generated using a simulation in which the
‘true’ drug efficacy (TDE) was evaluated by the FECRT under
varying conditions of samplesize, detection limit of the FEC methods,
level of excretion and aggregation of FEC across the host population.
Subsequently, the obtained data were analyzed using tree-based
models, to determine their impact on the interpretation of FECRT
and assess critical values in terms of specificity to detect normal
efficacy and sensitivity to detect reduced efficacy. Finally, the
outcome of these trees was validated on five trials previously
conducted to assess the efficacy of a single dose albendazole (400 mg)
in school children resident in Africa, Asia, and Latin America.
Data generation
Data were generated by Monte Carlo simulation as previously
described by Dobson et al. (2009) [14] and which was extended by
varying sample size, detection limito ft h eF E Cm e t h o d ,l e v e lo fe g g s
excreted, and level of aggregation of eggs across the hosts. To fully
understand this simulation, the various steps will be explained in more
detail.
First, the distribution of parasites within the host population before
administration of drugs was defined by a negative binomial
distribution. This distribution is determined by two parameters: the
mean level of egg excretion across subjects (mean pre-drug
administration (pre-DA) FEC) and the level of aggregation of FEC
across subjects (k). Low values of k indicate that only few subjects are
excreting the majority of eggs, where high values indicate that egg
counts are more normally distributed across the host population. From
this pre-defined distribution, a number of individual subjects were
randomly drawn representing the sample size. An example is given in
Table 1, where the outcome of such a random sample is shown for a
mean pre-DA FEC=250 EPG, k=1 and sample size=6.
The pre-DA FEC observed, however, will be different from the
‘true’pre-DAFECduetothevariation(i.e. stochasticity) introduced
by sampling eggs associated with the FEC method. This component
of variation was simulated using a Poisson distribution defined by
the expected number of eggs counted (=‘true’ host FEC/detection
limit). In Table 1, the expected number of eggs to be counted when
using a FEC method with a detection limit of 24 EPG (in casu the
standard Kato-Katz thick smear) for subject A with a ‘true’ subject
FECof796 EPGequaled 33.2 eggs (796/24).A randomsamplewas
then drawn from this pre-defined Poisson distribution, and for this
sample 35 eggs were observed, which was multiplied by 24
(detection limit) to obtain an observed pre-DA FEC of 840 EPG.
This procedure was repeated for each of the six subjects.
In order to simulate a TDE of 50%, the ‘true’ pre-DA FECs
were multiplied by 0.5 (1-TDE). The observed FEC after the
administration of the drug (post-DA FEC) was generated as
described above for the pre-DA FEC. Subsequently, the FECRT
was calculated as described in the formula below, resulting in an
observed reduction of 58.6% for the example provided in Table 1.
It is important to note that only one sample is examined per
subject and that all subjects are included in the calculation of the
FECRT, even those for whom the observed pre-DA FEC equaled
zero. Finally, the entire process was iterated 500 times, to obtain
500 estimates of FECRT for this pre-defined parasite population,
sample size, detection limit, and TDE.
FECRT (%)~100| 1{
arithmetic mean (post-DA FEC)
arithmetic mean (pre-DA FEC)

Author Summary
The reduction in number of eggs excreted in stools after
drug administration is a primary parameter to monitor the
efficacy of drugs against parasitic worms. Guidelines on
how to perform such a fecal egg count reduction test
(FECRT) are provided by the World Health Organization.
However, it remains unclear to which extent these
guidelines are cost-effective. We, therefore, performed a
simulation study in which the FECRT was performed under
varying conditions to determine the critical values for
sample size, the detection limit of the fecal egg count
(FEC) method, mean baseline FEC, and variation of FEC
across host population that allow for conclusive FECRT
results. The results revealed that a reliable monitoring
system demands a sample size of 200 subjects and that in
some cases FECRT results may be thwarted by low mean
baseline FEC. For this sample size, the detection of the FEC
method or the variation of FEC across the host population
did not affect the FECRT results. Our findings underscore
that the current guidelines are not cost-effective, demand-
ing too much financial and technical resources. We,
therefore, propose novel guidelines to support future
monitoring programs.
Monitoring Drug Efficacy against STH
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pre-DA FEC (50, 100, 150, 200, 250, 500, 750, and 1000 EPG)
and k (0.01, 0.025, 0.05, 0.075, 0.1, 0.25, 0.5, 0.75, 1, 1.5, and 2)
were based on previously conducted studies where STH were
quantified [9,15,16]. The values for the sample size were 6, 10, 15,
20, 25, 50, 75, 100, 125, 150, 175, and 200, covering a large range
of applied sample sizes to determine drug efficacy against STH
[16]. The values for the detection limit represented those of four
currently used FEC methods both in human and veterinary
parasitology: FLOTAC (detection limit=1 and 2 EPG) [17],
FECPAK (detection limit=5 and 10 EPG) (http://www.fecpak.
com), Kato-Katz thick smear (detection limit=12 and 24 EPG)
[18] and McMaster (detection limit=25, 33.3, and 50 EPG) [19].
The FEC methods used in veterinary medicine were included in
this analysis because they have recently been validated for the
diagnosis of STH in public health (FLOTAC [20] and McMaster
[21]). In addition, the inclusion of each of these additional assays
allowed assessing the impact of detection limit in greater depth.
The TDE was set on 50, 60, 70, 80, 82.5, 85, 87.5, 90, 92.5, 95,
97.5, and 99%, resulting in 114,048 combinations (8 (mean pre-
DA FEC)611 (k), 9 (detection limit)612 (sample size)612 (TDE))
that were each iterated 500 times.
Data analysis using tree-based models
The impact of the various factors on the sensitivity and
specificity of the FECRT was evaluated. Every TDE that was less
than 90 or 95% was considered as a truly reduced efficacy and as
truly efficacious if different. Both thresholds have been recently
suggested for hookworm and A. lumbricoides, respectively [9]. The
current threshold for T. trichiura (below 50%) was not included,
because its remains to be elucidated [22].
A combination of evaluated factors (500 iterations) was
considered to be ‘‘sensitive’’ (i.e. true test positive) when a FECRT
could be calculated (observed mean pre-DA FEC .0) and a truly
reduced efficacy (TDE ,90% or ,95%) was correctly detected in
at least 95% of the iterations or ‘‘insensitive’’ (i.e., false negative)
otherwise. A combination of evaluated factors was considered to
be ‘‘specific’’ (true test negative) when a FECRT could be
calculated (observed mean pre-DA FEC .0) and TDE $90 or
$95% was correctly detected in at least 95% of the iterations or
‘‘non-specific’’ (false positive) otherwise. In the example provided
in Table 1, more than 95% of the 500 iterations yielded a FECRT
below the defined thresholds, therefore, the FECRT for the
combination of a mean pre-DA FEC=250 EPG, k=1, detection
limit=24 EPG, and a sample size=6 was considered ‘sensitive’ to
detect the reduced efficacy of 50%. For this combination, the
specificity (correctly determine susceptibility when the STH are
drug-susceptible) cannot be evaluated as the TDE was below the
thresholds for reduced efficacy of both 90 and 95%.
Subsequently, tree-based models (classification trees) were built
in R using the packages ‘rpart’ and ‘randomforest’’ (version 2.10.0,
2009, The R Foundation for Statistical Computing) with both
sensitivity and specificity as a binary outcome variable (outcome
values are either 0 or 1) and the parasite-host population (mean
pre-DA FEC and k), the sample size, the detection limit, and the
TDE as continuous predictor variables [23].
Validation of classification trees
The sample sizes across the different trials were predicted by the
classification trees (predicted sample size) and subsequently
compared with those estimated by exact inference on the raw
data of five previously conducted efficacy trials (required sample
size). These trials evaluated the efficacy of a single dose
albendazole (400 mg) against A. lumbricoides (four out of five trials),
T. trichiura (three out of five trials) and hookworm infections (all five
trials) in school children in three countries in Africa (Cameroon,
Ethiopia and Tanzania), one country in Asia (Cambodia) and one
Latin American country (Brazil) [9]. These trails were selected for
two reasons. First, they were standardized in terms of the follow-up
(between 14 and 30 days after the administration of drug), the
detection technique (the McMaster egg counting method,
detection limit=50 EPG) and statistical analysis (see formula
above). Second, the prevalence of STH before the drug
administration exceeded 20% in each of these trials, and hence
meeting the criteria to implement preventive chemotherapy
programs [24]. For this validation all subjects screened at baseline
were included (subjects might be falsely classified as non-infected
due to the lack of sensitivity of the McMaster FEC method).
However, subjects with a baseline FEC of 0 EPG were not treated
nor re-examined at follow-up. To include these subjects it was
assumed that the FEC at follow-up of these non-infected subjects
(falsely/truly) also equaled zero after drug administration. In
addition to this, a number of infected subjects did not provide a
stool sample at follow-up. These subjects were replaced by a
random sample of subjects for which complete data were available.
The sample size, prevalence, mean pre-DA FEC, the aggregation
Table 1. A detailed example to illustrate the data generated by Monte Carlo simulation.
Host ID Pre-drug administration FEC (EPG) Post-drug administration FEC (EPG)
True counts Observed counts True counts Observed counts
A 796 840 398 288
B 120 168 60 0
C 172 144 86 96
D 212 288 106 120
E 258 240 129 168
F 100 0 50 24
Mean 276.2 280 138.1 116
FECRT (%) 50.0 58.6
The table shows a random sample of six subjects (A–F) drawn from a parasite-host population with a mean pre-drug administration fecal egg count (FEC) of 250 eggs
per gram of stool (EPG) and a k-value of 1, for a sample size of six in which a drug with a ‘true’ drug efficacy of 50% was evaluated by the fecal egg count reduction test
using a detection technique with a detection limit of 24 EPG.
doi:10.1371/journal.pntd.0001427.t001
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2/(variance FEC -
arithmetic mean FEC)) and the FECRT observed in these trials
are summarized in Table 2. For the validation of the statistical
methods, these values observed for FECRT, mean pre-DA FEC
and k are considered to be ‘true’ values.
The overall protocol of this multi-country study was approved by
the ethics committee of the Faculty of Medicine, Ghent University
(no. B67020084254) and was followed by a separate local ethical
approval for each study site. For Brazil, approval was obtained from
the institutional review board (IBR) from Centro de Pesquisas Rene ´
Rachou (no. 21/2008), for Cambodia from the national ethic
commitee for health research, for Cameroon from the national
ethics committee (no. 072/CNE/DNM08), for Ethiopia from the
ethical review board of Jimma University, for India from the IBR of
the Christian Medical College (no. 6541), for Tanzania (no. 20)
from the Zanzibar Health Research Council and the Ministry of
HealthandSocialWelfare,forVietnambythe MinistryofHealthof
Vietnam. An informed consentform was signed by the parents of all
subjects included in the trials. This clinical trial is registered under
the ClinicalTrials.gov, identifier NCT01087099.
The predicted sample sizes were deduced from the results of the
classification trees (Figures 1, 2, S2 and S3) and are shown in
Figure 3. For example, the predicted sample size to correctly
diagnosis a reduced efficacy against A. lumbricoides in the Brazilian
trial (FECRT=100%, mean pre-DA FEC=1,353 EPG and
k=0.063) ranged from 50 to 200 for both thresholds defining
reduced efficacy. When none of the combinations resulted in a
reliable diagnosis, the predicted sample size was set at .200, as
this was the largest sample size examined in the classification trees.
This was for example the case for the efficacy against T. trichiura
(FECRT=92.4%, mean pre-DA FEC=110 EPG and k=0.065)
in the Ethiopian trial, and this for both thresholds.
T h er e q u i r e ds a m p l es i z eb a s e do nt h er a wd a t ao ft h ed i f f e r e n t
trials was estimated by bootstrap analysis (re-sampling with
replacement and 10,000 iterations), as at present no formulae are
available to calculate sample size for the correct diagnosis of reduced
efficacy. In this analysis, different sample sizes were analyzed in order
to determine the smallest sample size for which FECRT could be
calculated (mean pre-DA FEC .0) and a truly reduced efficacy
(TDE ,90% or ,95%) was correctly detected in at least 95% of the
iterations or when a TDE $90 or $95% was correctly detected in at
least 95% of the iterations. The outcome of the bootstrap analysis for
Brazilian trial against A. lumbricoides described above is illustrated in
Figure S1. As the sample size increase, the probability of correctly
detecting a reduced efficacy increased. The required sample size
based on this trial was 17 for both thresholds.
In 24 cases the agreement between the required and the
predicted sample size was assessed (two thresholds (90 and
95%)612 FECRT (four for A. lumbricoides, three for T. trichiura
and five for hookworm). There was an agreement between the
required and the predicted sample size, if the exact required
sample size fell within the predicted sample size interval. For cases
where the required sample size did not fall within the predicted
sample size interval, it was assessed whether the required sample
size was overestimated (required sample size , lower limit of the
predicted sample size interval) or underestimated (required sample
size . upper limit of the predicted sample size).
Results
Detection of a normal or reduced efficacy for a threshold
of 90%
The classification-trees for the specificity to detect efficacy
$90% and sensitivity to detect reduced efficacy ,90% are
Table 2. The five trials used to validate the outcome of the classification trees.
Country (number of subjects,
prevalence of STH)
Mean pre-DA
FEC (EPG) k FECRT Threshold of 90% Threshold of 95%
Required Predicted Required Predicted
Brazil (n=350, 30.6%)
A. lumbricoides 1,353 0.063 100 17 50–200 17 50–200
Hookworm 101 0.097 97.5 30 10–49 176 50–200
Cambodia (n=1,026, 31.9%)
Hookworm 183 0.121 97.6 20 10–49 75 50–200
Cameroon (n=1,485, 44.1% )
A. lumbricoides 2,906 0.061 99.2 12 50–200 15 50–200
T. trichiura 331 0.042 39.2 32 50–200 22 50–200
Hookworm 59 0.015 93.0 4405 .200 .5000 50–200
Ethiopia (n=410, 61.0%)
A. lumbricoides 1,293 0.083 100 7 10–49 7 50–200
T. trichiura 110 0.065 92.4 1152 .200 1099 50–200
Hookworm 74 0.144 99.7 12 10–49 14 50–200
Tanzania (n=509, 95.3%)
A. lumbricoides 2,697 0.264 100 3 10–49 4 50–200
T. trichiura 832 0.781 52.0 6 10–49 4 50–200
Hookworm 706 0.572 95.3 78 10–49 .5000 .200
Cases highlighted in bold indicate an agreement between the required and the predicted sample size (the required sample size fell within the sample size interval
predicted). Cases highlighted in italic indicate an underestimation of the required sample size (required sample size . upper limit of the predicted sample size interval).
In the remaining cases, the required sample size was overestimated (required sample size . lower limit of the predicted sample size).
doi:10.1371/journal.pntd.0001427.t002
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www.plosntds.org 4 December 2011 | Volume 5 | Issue 12 | e1427Figure 1. The classification tree of the factors affecting FECRT specificity (TDE $90%). The classification tree of the factors affecting FECRT
specificity (%) (correct detection of a ‘true’ drug efficacy (TDE) $90%); factors included mean fecal egg count (FEC) before administration of drugs
(pre-DA FEC), aggregation of FEC (k), sample size, detection limit, and TDE. N=number of combinations.
doi:10.1371/journal.pntd.0001427.g001
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colored green when the specificity/sensitivity was reliable ($85%),
and red if different.
The specificity was evaluated in the 47,520 combinations were
the TDE was $90% and was affected with decreasing importance
(increasing number of bifurcations from the root node) by TDE,
sample size and aggregation of the FEC (k). The detection limit
and mean pre-DA FEC did not considerably influence the
specificity, since these parameters did not result in any bifurcation
across the classification tree. From the red-green color code to
define a reliable specificity, it can be deducted that false positive
conclusions concerning reduced efficacy were drawn when the
TDE was between 90 and 92.5% (specificity=0%, n=9,504). For
a TDE $92.5%, reliable specificity results depended on the
sample size. For small sample sizes (,50 subjects), reliable
conclusions could only be drawn when lowly aggregated FEC
(k$0.05) were combined with TDE $95% and a sample size of at
least 10 subjects (specificity=89.8%, n=7,776). For large sample
sizes ($50), specificity was always high, regardless of the
aggregation of the FEC and TDE (specificity=96.0%,
n=22,176).
The sensitivity was evaluated in the remaining 66,528
combinations where the TDE did not exceed 90%. The most
important factor affecting the sensitivity was the sample size,
followed by both TDE and aggregation of the FEC and finally the
mean pre-DA FEC. The detection limit did not considerably
influence the sensitivity. For sample sizes ,50, reduced efficacies
were only correctly diagnosed when lowly aggregated FEC
(k$0.075) were combined with a TDE ,82.5% and a sample
size of $10 (sensitivity=90.3%, n=11,520).
For sample sizes $50, the diagnosis of reduced efficacy
depended on the TDE. For TDE between 85.0% and 87.5%,
satisfactory sensitive results were only found when mean pre-DA
FEC were high ($150 EPG) (sensitivity=88.3%, n=4,158). For
TDE ,85.0%, sensitivity was high (=98.1, n=33, 264),
regardless of the mean pre-DA FEC.
The combinations that result in a reliable detection of a normal
or reduced efficacy (sensitivity and specificity .85%) and their
respective TDE limits for which the FECRT cannot reliably
provide a correct diagnosis (‘grey’ zone) are summarized in
Figure 3. All combinations resulted in a reliable classification of
efficacy status, except for small sample sizes (,10) and moderate
sample sizes (10–49) combined with highly aggregated FEC (k
,0.075). The TDE limits for sensitivity (TDE=82.5%) and
specificity (TDE=95%) that were least discriminatory occurred
for moderate sample sizes (10–49) combined with low aggregated
FEC (k$0.075). Best discrimination TDE limits for sensitivity and
specificity were 87.5% and 92.5%, respectively, and occurred for
large sample sizes (50–200) combined with high mean pre-DA
FEC ($150 EPG).
Detection of a normal or reduced efficacy for a threshold
of 95%
For the reduced efficacy threshold of 95%, only the combina-
tions, which result in a reliable classification of efficacy status and
their TDE limits in which FECRT results are unreliable, are
reported (Figure 3). The classification trees of the specificity and
sensitivity are provided in Figures S2 and S3, respectively.
Compared to a reduced efficacy defined as TDE ,90%, there
were three important differences. First, the pre-DA FEC did not
Figure 2. The classification tree of the factors affecting FECRT sensitivity (TDE ,90%). The classification tree of the factors affecting FECRT
sensitivity (%) (correct detection of a reduced efficacy when ‘true’ drug efficacy (TDE) ,90%); factors included mean fecal egg count (FEC) before
administration of drugs (pre-DA FEC), aggregation of FEC (k), sample size, detection limit, and TDE. N=number of combinations.
doi:10.1371/journal.pntd.0001427.g002
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had a considerable impact on the interpretation of FECRT. A
detection limit $15 did not always allow a reliable FECRT,
particularly for sample sizes ,50 subjects. Finally, there was a
difference in the critical value(s) for sample size (10 and 50 for 90%
threshold vs. 10, 25, and 50 for the 95% threshold) and
aggregation of the FEC (0.075 vs. 0.05 and 0.25). The least
discriminatory TDE limits for which conclusions were doubtful
was found when moderate sample sizes (10–24) were combined
with a high detection limit (,15 EPG) and lowly aggregated FEC
$0.25. For these combinations TDE limits were 87.5% to 97.5%
for sensitivity and specificity, respectively. Best discrimination
(TDE 92.5% and 97.5% for sensitivity and specificity respectively)
was observed for moderate sample sizes (25–49) combined with
high detection limits (,15 EPG) and for large sample sizes ($50
subjects) regardless of the detection limit.
Validation of the classification trees
The predicted and the required sample sizes across the different
trials for both a normal and a reduced efficacy ,90 and ,95% are
provided in Table 2. Overall, there was an agreement between the
predicted and the required sample size in eight out of 24 cases
(highlighted in bold). In the 16 remaining cases, the required
sample size fell out of the interval of predicted sample size. Yet, the
required sample was only underestimated in three cases (high-
lighted in italic). In the remaining 13 cases, the required sample
size was overestimated (not highlighted). There was a slight
variation in agreement between the required and predicted sample
size across the two thresholds defining reduced efficacy. For a
threshold of 90%, there was an agreement between the required
and the predicted sample size in five cases, whereas this was only
observed in three cases for a threshold of 95%. Moreover, two out
of the three cases for which the required sample size was
underestimated were found for the latter threshold.
Discussion
In the present study, the most applied test to evaluate
anthelmintic drug efficacy against A. lumbricoides and hookworm
in public health, was virtually performed under varying conditions
of sample size, detection limit of the FEC method, level of
excretion, and aggregation of eggs within the host population.
Subsequently, tree-based models were built to assess the impact of
these factors on the specificity and the sensitivity to detect normal
or reduced efficacy. Finally, the outcomes of these models were
validated on different efficacy trials done in Africa, Asia and Latin
America.
The present study provides novel insights into three aspects of
FECRT. The first important finding is that a successful
interpretation of the FECRT is not always possible and that this
is not always due to factors inherent to the design of a study, but
can also be caused by factors inherent to host-parasite interactions
(e.g., level of excretion and aggregation of eggs within the host
Figure 3. The detection of reduced efficacy when defined as ‘true’ drug efficacy ,90% and ,95%. Only combinations of sample size (n),
mean fecal egg count before drug administration (mean pre-DA FEC), detection limit and aggregation (k), which resulted in a reliable FECRT
(sensitivity (Se) and specificity (Sp) $85%) are shown. Also shown are TDE limits for Se and Sp, which caused Se and Sp ,85%.
doi:10.1371/journal.pntd.0001427.g003
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FECRT results were obtained when sample sizes were small or
when moderate sample sizes were combined with highly
aggregated FEC. For a threshold of 95% (A. lumbricoides),
diagnostic performance was poor when sample sizes are small
and when moderate sample sizes were combined with highly
aggregated FEC and/or with FEC methods with a low detection.
Second, our results highlight that the interval of TDE for which
the FECRT remains inconclusive (so called ‘grey’ zone, Figure 3)
is unexpectedly small, ranging from 87.5% to 92.5% for
hookworm and from 92.5% to 97.5% for A. lumbricoides. Third,
the study design with the greatest discriminatory power to classify
drug efficacy requires examination of 50 to 200 subjects, for both
hookworm and A. lumbricoides. For this interval of sample sizes,
there were no additional requirements on the detection limit of the
FEC method and the level of aggregation of the FEC did
considerably influence the interpretation of the FECRT. Only for
hookworm, mean pre-DA FEC ,150 EPG led to a less reliable
interpretation of FECRT, as the ‘grey’ zone ranged from 85.0% to
92.5%.
Overall, our findings contrast sharply with the recommenda-
tions provided by WHO [10], explained by two main reasons.
First, our analysis indicates that including subjects with any STH
status (absence (true or falsely) or presence of eggs in stool) will not
affect the final interpretation of the FECRT, yet this allows a
dramatic reduction in the required sample size. For example,
monitoring drug efficacy in a low risk-population (STH preva-
lence=20%) would require screening 1,000 subjects (in order to
obtain a sample size of 200 infected subjects) according to WHO
guidelines, whereas according to our findings only 50 to 200
subjects are required. This, however, remains a large interval of
possible sample sizes, which requires further refinement. The
outcome of the efficacy used to validate the tree-based models,
indicated that a minimum of 200 subjects are recommend, as this
sample size allowed for a reliable detection of normal or reduced
efficacy in all 14 trials where the FECRT fell outside the ‘grey’
zone. Second, our results do not support the need for four fecal
samples per subject (two before and two after administration of
drugs), and hence will further reduce the costs to implement a
monitoring system. This is mainly based on the fact that in the
present simulation of FECRT based on two stool samples per
subject (one before and one after administration of drugs), and
hence partially ignoring any variation in FEC due to differences in
FEC across days, did not result in an underestimation of the
required sample size. Moreover, the detection limit of the FEC
method revealed to be less critical than anticipated, highlighting
the importance of the feasibility of the FEC method used.
Recently, Kato-Katz thick smear, FLOTAC, and McMaster egg
counting methods have been compared for their feasibility in
diagnosing STH [13,25]. Of these three methods, McMaster egg
counting method was considered the most feasible, as the
procedure does not include centrifugation steps (vs. FLOTAC)
and allows quantifying all STH in one single reading (vs. Kato-
Katz thick smear). Based on these studies assessing the cost of these
diagnostic methods, it is estimated that the average time for
preparing, reading and examining one stool sample is roughly
5 min for McMaster egg counting method, 10 min for Kato-Katz
thick smear, and 26 min for FLOTAC [13,25].
The combination of different statistical procedures (Monte
Carlo simulation and tree-based models), allowed for a cost-
reduced data generation providing a decision support framework
rather than a descriptive analysis. At present, both approaches are
increasingly applied in various aspects of both public [26] and
animal health [27]. However, this statistical approach to evaluate
FECRT has limitations that must be acknowledged. First, it is
assumed that worm abundance is adequately reflected by FECs,
yet it remains unclear whether this holds true for STH infections in
humans, particularly for hookworms. For this STH, a density
dependent fecundity - female worms that survived the anthelmin-
tic treatment produce relatively more eggs - has been described in
dogs (Ancylostoma caninum) [28]. These density dependent effects
imply a reduced drug efficacy for subjects with higher pre-
intervention FEC, but this has not yet been observed in human
trials [9]. Secondly, the generation of the observed FEC did not
consider additional variation caused by properties of the detection
technique beyond the detection limit, which impedes a straight-
forward extrapolation of the findings across FEC methods. Both
the specific density of the flotation solution (large difference in
mass of parasite eggs) [29] and the inclusion of a centrifugation
step (increasing FEC when included) have an important impact on
the FEC obtained by various FEC methods [30]. For Kato-Katz
thick-smear, the templates used to substitute the calibrated weight
of examined stool by a calibrated volume introduce an additional
variation [25,31]. Additionally, differences in processing samples
across investigators or laboratories should not be neglected
[25,31–33]. As a consequence, it will become necessary to
quantitatively validate the ability of both old and novel techniques
to determine true FECRT rather than simply compare their ability
to correctly diagnose the presence or absence of infections [12].
Thirdly, this simulation did not include any STH populations
defined by a mean baseline FEC ,50 EPG and/or a k ,0.01.
Although this kind of populations are to be expected after a
successful implementation of preventive chemotherapy programs,
the simulation still represents a significant part of the populations
at risk of STH infections. This is in particular when the target to
administer anthelmintics to at least 75% of the population at risk
by 2010 set by World Health Assembly Resolution 54.19 in 2001,
was not met (coverage was ,20% in 2008) [34]. Moreover, it is
most likely that by then the endpoints of these programs will shift
from ‘reducing morbidity’ to ‘eradicating’ of STH infections,
which will demand a shift in study design and efficacy indicators of
monitoring programs of anthelmintic efficacy.
In conclusion, this study points out that the final interpretation
of the FECRT was affected by a complex interplay of factors
inherent to both study design and host-parasite interaction. The
results also indicate that current WHO guidelines need to be
revised. Based on the current study and the outcome of previously
assessed efficacy trials [9], we propose to include a minimum of
200 subjects independent of STH status (subjects who are not
excreting eggs can also be included) and to examine two stool
samples per subject (one at baseline and one at follow-up). In this
set-up, the choice of FEC method is not critical and arithmetic-
mean based FECR ,95% for A. lumbricoides and ,90% for
hookworms can be used as indicators for reduced efficacy and
potential presence of drug resistance against albendazole.
Supporting Information
Figure S1 The required sample size based on bootstrap
analysis for the Brazilian trial against A. lumbricoides.
The required sample size based on bootstrap analysis (10,000
iterations) for the correct diagnosis of reduced efficacy ,90% and
,95% in the Brazilian trial against A. lumbricoides.
(TIF)
Figure S2 The classification tree of the factors affecting
FECRT specificity (TDE $95%). The classification tree of the
factors affecting FECRT specificity (%) (correct detection of a
‘true’ drug efficacy (TDE) $95%); factors included mean fecal egg
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www.plosntds.org 8 December 2011 | Volume 5 | Issue 12 | e1427count before administration of drugs (pre-DA FEC), aggregation
of FEC (k), sample size, detection limit, and TDE. N=number of
combinations.
(TIF)
Figure S3 The classification tree of the factors affecting
FECRT sensitivity (TDE ,95%). The classification tree of the
factors affecting FECRT sensitivity (%) (correct detection of a
reduced efficacy when ‘true’ drug efficacy (TDE) was ,95%);
factors included mean fecal egg count before administration of
drugs (pre-DA FEC), aggregation of FEC (k), sample size,
detection limit, and TDE. N=number of combinations.
(TIF)
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